Becton Dickinson and Co vs Charles Schwab Corporation Common Stock — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Charles Schwab Corporation Common Stock trades at $107.87 (market cap $186.25B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 3.8× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| BDX | SCHW | |
|---|---|---|
Market Cap | $49.41B | $186.25B |
Sector | Health | Financials |
52-Week High | $185.39 | $108.02 |
52-Week Low | $138.62 | $85.35 |
Enterprise Value | $65.51B | — |
Dividend Yield | 2.32% | 1.19% |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →